147 related articles for article (PubMed ID: 31830631)
1. Evaluation of rectal dose discrepancies between planned and in vivo dosimetry using MOSkin detector and PTW 9112 semiconductor probe during
Jamalludin Z; Jong WL; Malik RA; Rosenfeld AB; Ung NM
Phys Med; 2020 Jan; 69():52-60. PubMed ID: 31830631
[TBL] [Abstract][Full Text] [Related]
2. Correlation analysis of CT-based rectal planning dosimetric parameters with in vivo dosimetry of MOSkin and PTW 9112 detectors in Co-60 source HDR intracavitary cervix brachytherapy.
Jamalludin Z; Malik RA; Ung NM
Phys Eng Sci Med; 2021 Sep; 44(3):773-783. PubMed ID: 34191272
[TBL] [Abstract][Full Text] [Related]
3. In-vivo Comparison of Planned and Measured Rectal Doses during Cobalt-60 HDR CT-based Intracavitary Brachytherapy Applications of Cervical Cancer Using the PTW 9112 Semiconductor Probe.
Johan SK; Lobo D; Athiyamaan MS; Srinivas C; Banerjee S; Abhishek K; Saxena PUP
Asian Pac J Cancer Prev; 2023 Mar; 24(3):897-907. PubMed ID: 36974543
[TBL] [Abstract][Full Text] [Related]
4. In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed doses.
Carrara M; Tenconi C; Rossi G; Borroni M; Cerrotta A; Grisotto S; Cusumano D; Pappalardi B; Cutajar D; Petasecca M; Lerch M; Gambarini G; Fallai C; Rosenfeld A; Pignoli E
Radiother Oncol; 2016 Jan; 118(1):148-53. PubMed ID: 26796593
[TBL] [Abstract][Full Text] [Related]
5. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of MOSkin dosimeters to rectal wall in vivo dosimetry in gynecological HDR brachytherapy.
Carrara M; Romanyukha A; Tenconi C; Mazzeo D; Cerrotta A; Borroni M; Cutajar D; Petasecca M; Lerch M; Bucci J; Richetti A; Presilla S; Fallai C; Gambarini G; Pignoli E; Rosenfeld A
Phys Med; 2017 Sep; 41():5-12. PubMed ID: 28499627
[TBL] [Abstract][Full Text] [Related]
7. Characterization of MOSkin detector for in vivo dose verification during Cobalt-60 high dose-rate intracavitary brachytherapy.
Jamalludin Z; Jong WL; Abdul Malik R; Rosenfeld A; Ung NM
Phys Med; 2019 Feb; 58():1-7. PubMed ID: 30824140
[TBL] [Abstract][Full Text] [Related]
8. Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement.
Legge K; Greer PB; O'Connor DJ; Wilton L; Richardson M; Hunter P; Wilfert A; Martin J; Rosenfeld A; Cutajar D
Radiat Oncol; 2017 Feb; 12(1):41. PubMed ID: 28241841
[TBL] [Abstract][Full Text] [Related]
9. In vivo dosimetry using MOSkin detector during Cobalt-60 high-dose-rate (HDR) brachytherapy of skin cancer.
Jamalludin Z; Jong WL; Ho GF; Rosenfeld AB; Ung NM
Australas Phys Eng Sci Med; 2019 Dec; 42(4):1099-1107. PubMed ID: 31650362
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of treatment planning system of brachytherapy according to dose to the rectum delivered.
Allahverdi M; Sarkhosh M; Aghili M; Jaberi R; Adelnia A; Geraily G
Radiat Prot Dosimetry; 2012 Jul; 150(3):312-5. PubMed ID: 22128355
[TBL] [Abstract][Full Text] [Related]
11. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
12. Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters.
Poder J; Howie A; Brown R; Bucci J; Rosenfeld A; Enari K; Schreiber K; Carrara M; Bece A; Malouf D; Cutajar D
Radiother Oncol; 2020 Oct; 151():273-279. PubMed ID: 32798597
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
Sha RL; Reddy PY; Rao R; Muralidhar KR; Kudchadker RJ
Med Dosim; 2011; 36(4):377-82. PubMed ID: 21144733
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy.
Haughey A; Coalter G; Mugabe K
Australas Phys Eng Sci Med; 2011 Sep; 34(3):361-6. PubMed ID: 21710233
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques.
Kapp KS; Stuecklschweiger GF; Kapp DS; Hackl AG
Radiother Oncol; 1992 Jul; 24(3):137-46. PubMed ID: 1410567
[TBL] [Abstract][Full Text] [Related]
16. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
17. In vivo diode dosimetry vs. computerized tomography and digitally reconstructed radiographs for critical organ dose calculation in high-dose-rate brachytherapy of cervical cancer.
Hassouna AH; Bahadur YA; Constantinescu C; El Sayed ME; Naseem H; Naga AF
Brachytherapy; 2011; 10(6):498-502. PubMed ID: 21640661
[TBL] [Abstract][Full Text] [Related]
18. A phamtom study: In vivo rectal dosimetry of high dose rate brachytherapy in cervical cancer.
Moonkum N; Turathong S; Pinitpatcharalert A; Seechompoo J; Suetong C; Danthanavat N; Tochaikul G
Appl Radiat Isot; 2023 Feb; 192():110604. PubMed ID: 36495786
[TBL] [Abstract][Full Text] [Related]
19. In vivo dosimetry with semiconductors in medium dose rate (MDR) brachytherapy for cervical cancer.
Allahverdi M; Jaberi R; Aghili M; Ghahremani F; Geraily G
Jpn J Radiol; 2013 Mar; 31(3):160-5. PubMed ID: 23207645
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of two-dimensional radiography and three dimensional computed tomography based dose-volume parameters for high-dose-rate intracavitary brachytherapy of cervical cancer: a prospective study.
Madan R; Pathy S; Subramani V; Sharma S; Mohanti BK; Chander S; Thulkar S; Kumar L; Dadhwal V
Asian Pac J Cancer Prev; 2014; 15(11):4717-21. PubMed ID: 24969909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
